Quinolines and pharmaceutical compositions thereof
US7576215B2 · kind B2 · utility
14Cited by
12References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2004 |
| Grant date | Aug 18, 2009 |
| Priority date | — |
| Expiry date | May 29, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides compounds of formula Ithat are useful in the treatment or inhibition of LXR mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.